Elbasvir N-1 is a chemical compound primarily recognized for its role as an antiviral agent, specifically in the treatment of hepatitis C virus (HCV) infections. It functions as an inhibitor of the HCV NS5A protein, which is crucial for viral replication and assembly. The compound is characterized by its specific molecular structure, which includes various functional groups that contribute to its biological activity and pharmacokinetic properties. Elbasvir N-1 is typically administered in combination with other antiviral medications to enhance therapeutic efficacy and reduce the likelihood of resistance development. Its pharmacological profile includes favorable absorption characteristics, a moderate half-life, and a metabolism primarily through hepatic pathways. Safety and efficacy profiles are established through clinical trials, and it is essential to monitor for potential side effects and drug interactions when used in therapeutic regimens. Overall, Elbasvir N-1 represents a significant advancement in the pharmacotherapy of hepatitis C, contributing to improved patient outcomes.

Elbasvir N-1

1392102-38-3: (6S)-3,10-Dibromo-6-phenyl-6H-indolo[1,2-c][1,3]benzoxazine, (S)-3,10-dibromo-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole, 6H-Indolo[1,2-c][1,3]benzoxazine, 3,10-dibromo-6-phenyl-, (6S)-

(S)-3,10-dibromo-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole

Please enquire for more information about (S)-3,10-Dibromo-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole including the price, delivery time and more detailed product information at the technical inquiry form on this page

CAS 1392102-38-3: Elbasvir N-1

(S)-3,10-dibromo-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole

Ref: IN-DA009CLV

(S)-3,10-Dibromo-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole

Ref: 3D-FD168251

(S)-3,10-dibromo-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole

Ref: 54-OR93633